This product is for research use only, not for human use. We do not sell to patients.
Size | Price |
---|---|
250mg | Get quote |
500mg | Get quote |
1g | Get quote |
Cat #: V3307 CAS #: 548486-59-5 Purity ≥ 98%
Description: Ulodesine (formerly also known as BCX4208) is a novel and potent inhibitor of purine nucleoside phosphorylase (PNP) with the potential to be used for the treatment of psoriasis and gout. It inhibits PNP with an IC50 of 0.5 nM. It is currently being developed by Biocryst as a once-daily oral, chronic treatment for gout. Ulodesine acts at the upstream of xanthine oxidase in the purine metabolism pathway to reduce the production of serum uric acid (sUA) by inhibiting PNP. BCX-4208 is currently in early clinical investigation in psoriasis and gout.
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
Molecular Weight (MW) | 264.28 |
---|---|
Molecular Formula | C12H16N4O3 |
CAS No. | 548486-59-5 |
Storage | -20℃ for 3 years in powder form |
-80℃ for 2 years in solvent | |
Solubility In Vitro | DMSO: ≥ 10mg/mL |
Water: N/A | |
Ethanol: N/A | |
SMILES Code | O=C1C(NC=C2CN3C[C@H](O)[C@@H](CO)C3)=C2N=CN1 |
Synonyms | BCX4208; BCX-4208; BCX 4208; DADMe-immucillin H |
Solvent volume to be added | Mass (the weight of a compound) | |||
---|---|---|---|---|
Mother liquor concentration | 1mg | 5mg | 10mg | 20mg |
1mM | 3.7839 mL | 18.9193 mL | 37.8387 mL | 75.6773 mL |
5mM | 0.7568 mL | 3.7839 mL | 7.5677 mL | 15.1355 mL |
10mM | 0.3784 mL | 1.8919 mL | 3.7839 mL | 7.5677 mL |
20mM | 0.1892 mL | 0.9460 mL | 1.8919 mL | 3.7839 mL |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.